Raphael Pharmaceutical (RAPH) EPS (Basic) (2020 - 2026)
Raphael Pharmaceutical's (RAPH) quarterly EPS (Basic) came in at -$0.01 in Q2 2026, up 38.55% year-over-year from -$0.01 in Q2 2025, and up 38.55% quarter-over-quarter from -$0.02 in Q2 2025.
Powered by 
Analysis
Raphael Pharmaceutical (RAPH) EPS (Basic) (2020 - 2026) Analysis & Trends
Raphael Pharmaceutical has disclosed EPS (Basic) across 7 years of filings, most recently posting -$0.01 for Q2 2026.
- In Q2 2026, EPS (Basic) rose 38.55% year-over-year to -$0.01; the TTM figure through Jun 2026 stood at -$0.06 (up 6.53% YoY), while the FY2025 annual figure was -$0.06, up 21.2% from the prior year.
- EPS (Basic) came in at -$0.01 for Q2 2026 at Raphael Pharmaceutical, up from -$0.02 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.01 in Q4 2023 to a low of -$0.09 in Q3 2022.
- Average EPS (Basic) over 5 years is -$0.03, with a median of -$0.02 recorded in 2024.
- Year-over-year, EPS (Basic) surged 110.41% in 2023 and tumbled 363.21% in 2024.
- Over 5 years, EPS (Basic) stood at -$0.08 in 2022, then soared by 110.41% to $0.01 in 2023, then plunged by 363.21% to -$0.02 in 2024, then grew by 23.93% to -$0.02 in 2025, then jumped by 38.55% to -$0.01 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.01 in Q2 2026, -$0.02 in Q2 2025, and -$0.02 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -0.40 |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | -0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01 |
| Jun 30, 2025 | -0.02 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | -0.02 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | -0.03 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | -0.04 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | -0.08 |
| Sep 30, 2022 | -0.09 |
| Jun 30, 2022 | -0.04 |
| Mar 31, 2022 | -0.01 |
| Dec 31, 2021 | -0.05 |
| Sep 30, 2021 | -0.03 |
| Jun 30, 2021 | -0.04 |
| Mar 31, 2021 | -0.03 |
| Dec 31, 2020 | -0.02 |